+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BioMarin Pharmaceutical Inc. - logo

BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes. They are leaders in metabolic disease innovation with multiple products commercialized and a pipeline of product candidates to address unmet medical needs. BioMarin's headquarters are based in Novato, California, United States.

From
From
Disease Analysis: Hemophilia - Product Thumbnail Image

Disease Analysis: Hemophilia

  • Report
  • June 2021
  • 102 Pages
  • Global
Neurofibromatosis Treatment Market Report 2025 - Product Thumbnail Image

Neurofibromatosis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Pompe Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Pompe Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Phenylketonuria- Pipeline Insight, 2025 - Product Thumbnail Image

Phenylketonuria- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Lewy Body Dementia Treatment Market Report 2025 - Product Thumbnail Image

Lewy Body Dementia Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Hypertrophic Cardiomyopathy- Pipeline Insight, 2025 - Product Thumbnail Image

Hypertrophic Cardiomyopathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gene Therapy Market Report 2025 - Product Thumbnail Image

Gene Therapy Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
DNA Repair Drugs Market Report 2025 - Product Thumbnail Image

DNA Repair Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Glycomic Therapeutics Market Report 2025 - Product Thumbnail Image

Glycomic Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Potassium Channel Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Potassium Channel Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Bi-Specific MAbS Market Report 2025 - Product Thumbnail Image

Bi-Specific MAbS Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Mucopolysaccharidosis III - Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis III - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator